KELCI GILLENWATER: Open Payments
NPI 1962887109 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 13 payments from 5 companies in 2025. Trend: 2023 $342 · 2024 $526 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| ABBVIE INC. | 5 | $86 |
| Celltrion USA Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| PFIZER INC. | 1 | $16 |
Products named: ENTYVIO, SKYRIZI, RINVOQ, VEGZELMA, XIFAXAN, XELJANZ, LINZESS.
Industry payments across KS — which companies pay providers there.
